Trends in thyroid hormone prescribing and consumption in the UK

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Mitchell, Anna L ^a   Hickey, Bryan ^b   Hickey, Janis L ^b   Pearce, Simon H S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BRITISH THYROID FOUNDATION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARMOUR THYROID; LEVOTHYROXINE; LIOTHYRONINE; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG; PRESCRIPTION DRUG;

ARTICLE; COMMUNITY; DRUG COST; HEALTH CARE POLICY; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; NON PROFIT ORGANIZATION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRESCRIPTION; UNITED KINGDOM; CLINICAL PRACTICE; COST; DRUG UTILIZATION; ECONOMICS; EPIDEMIOLOGY;

COSTS AND COST ANALYSIS; DRUG COSTS; DRUG UTILIZATION; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; THYROID HORMONES; THYROXINE;

EID: 66149093768     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-132     Document Type: Article

References (16)

1. Prescription cost analysis statistics. Department of Health. http://www.dh.gov.uk/en/PublicationsAndStatistics/Statistics/ StatisticalWorkAreas/StatisticalHealthCare/DH-4086488
2. Management of hypothyroidism in adults. B Vaidya SHS Pearce, BMJ 2008 337 a801 10.1136/bmj.a801 18662921
3. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audut and Research Study (TEARS). GP Leese RV Flynn RT Jung TM MacDonald MJ Murphy AD Morris, Clin Endo 2008 68 311 316
4. Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of sheep. GP Murray, BMJ 1891 2 796 10.1136/bmj.2.1606.796
5. Chemistry of Thyroxine - Constitution and Synthesis of Thyroxine. CR Harington G Barger, Biochemical Journal 1927 21 169 183 16743801
6. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. R Bunevicius G Kazanavicius R Zalinkevicius AJ Prange Jr, N Engl J Med 1999 340 424 429 10.1056/NEJM199902113400603 9971866
7. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism - meta-analysis of randomized controlled trials. S Grozinsky-Glasberg A Fraser E Nahshoni A Weizman L Leibovici, J Clin Endocrin Metab 2006 91 2592 2599 10.1210/jc.2006-0448
8. Triiodothyronine and thyroxine content of desiccated thyroid tablets. RW Rees-Jones PR Larsen, Metabolism 1977 26 1213 8 10.1016/0026-0495(77)90113-5 909397
9. Identification and quantification of medication returned to Otago pharmacies. R Braund YC Yuen J Jung, NZFP 2007 34 258 262
10. A comparison of 28 and 56 day prescribing practices. L Gatley F Rooney H Chrystyn, Pharmaceutical Journal 1995 255 6868 R34
11. A detailed analysis of the day to day unwanted medicinal products returned to community pharmacies for disposal. GM Hawksworth DJ Wright H Chrystyn, Journal of Social and Administrative Pharmacy 1996 13 215 222 (Pubitemid 27116001)
12. Restricting patients' medication supply to one month: saving or wasting money? ME Domino J Olinick B Sleath S Leinwand PJ Byrns T Carey, Am J Health Sys Pharm 2004 61 1375 9 (Pubitemid 39481444)
13. The cost effectiveness of treatment modalities for thyrotoxicosis in a UK centre. NN Patel P Abraham J Boscombe MPJ Vanderpump, Thyroid 2006 16 593 598 10.1089/thy.2006.16.593 16839261
14. 28 day prescribing. The North Nottinghamshire prescribing strategy group, 1999 http://www.ukmicentral.nhs.uk/guide/docs/NN-28DayPrescribing.pdf
15. Restriction of levothyroxine prescriptions - inconvenient for patients and economically ineffective. JL Hickey W Beckett SHS Pearce, Letter to the BMJ 2007 http://www.bmj.com/cgi/eletters/334/7603/1076-a
16. Behavioural incentives gone mad? The report of the National Audit Office into prescribing costs in primary care. KG White JAH Wass J Monson, Letter to the BMJ 2007 http://www.bmj.com/cgi/eletters/334/7603/1076-a